Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Clinical Dermatology"
DOI: 10.1007/s40257-018-0363-8
Abstract: Cutaneous and systemic lupus erythematosus (SLE) commonly involves the hair and scalp. Alopecia can result from direct activity of disease on the scalp or from the state of physical stress in the form of telogen… read more here.
Keywords: hair scalp; systemic lupus; lupus erythematosus; cutaneous systemic ... See more keywords
Identification of key genes and immune profile in limited cutaneous systemic sclerosis-associated pulmonary arterial hypertension by bioinformatics analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Life sciences"
DOI: 10.1016/j.lfs.2021.119151
Abstract: AIMS Limited cutaneous systemic sclerosis-associated pulmonary arterial hypertension (lcSSc-PAH) is a complex multi-system disease with high morbidity and mortality. The purpose of this study is to identify the hub genes and immune characteristics of limited… read more here.
Keywords: analysis; systemic sclerosis; cutaneous systemic; lcssc pah ... See more keywords
SP144RENAL AND CUTANEOUS SYSTEMIC VASCULITIS IN PATIENTS ADDICTED TO COCAINE-LEVAMISOLE: A MISSED DIAGNOSIS?
Sign Up to like & getrecommendations! Published in 2017 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfx141.sp144
Abstract: • We describe a series of five cases in patients of southern Brazil who were chronic users of cocaine/levamisole and presented skin lesions and/or acute kidney injury. • Patient ́s medical records were reviewed and… read more here.
Keywords: vasculitis patients; patients addicted; sp144renal cutaneous; systemic vasculitis ... See more keywords
P152 Skin score trajectory associates with survival and pulmonary outcome in diffuse cutaneous systemic sclerosis
Sign Up to like & getrecommendations! Published in 2020 at "Rheumatology"
DOI: 10.1093/rheumatology/keaa111.147
Abstract: Skin thickness improves over time in most diffuse cutaneous systemic sclerosis (dcSSc) patients and the use of group level skin score (mRss) as an endpoint is clinical trials can be challenging. We explore the association… read more here.
Keywords: risk; mrss; skin; diffuse cutaneous ... See more keywords
Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis.
Sign Up to like & getrecommendations! Published in 2021 at "Rheumatology"
DOI: 10.1093/rheumatology/keab604
Abstract: OBJECTIVES The aim of this study was to explore outcomes in a cohort of diffuse cutaneous systemic sclerosis (dcSSc) patients fulfilling eligibility criteria for stem cell transplantation (SCT) studies but receiving standard immunosuppression. METHODS From… read more here.
Keywords: cell transplantation; stem cell; diffuse cutaneous; systemic sclerosis ... See more keywords
Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: an international collaborative scoping review.
Sign Up to like & getrecommendations! Published in 2022 at "Rheumatology"
DOI: 10.1093/rheumatology/keac049
Abstract: OBJECTIVES to comprehensively identify instruments within relevant domains employed to assess limited cutaneous systemic sclerosis (lcSSc) since the endorsement of its consensus definition in 1988. The overall objective is to inform the creation of a… read more here.
Keywords: systemic sclerosis; limited cutaneous; assessment; literature ... See more keywords
Clinical worsening following discontinuation of tocilizumab in diffuse cutaneous systemic sclerosis: a single-centre experience in Japan.
Sign Up to like & getrecommendations! Published in 2022 at "Rheumatology"
DOI: 10.1093/rheumatology/keac136
Abstract: OBJECTIVE To investigate outcomes following the tapering or discontinuation of tocilizumab in patients with diffuse cutaneous systemic sclerosis (dcSSc) in a real-world setting. METHODS Fifteen patients who were treated with tocilizumab for dcSSc were selected… read more here.
Keywords: systemic sclerosis; discontinuation tocilizumab; tocilizumab; diffuse cutaneous ... See more keywords
A Phase II randomised controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS).
Sign Up to like & getrecommendations! Published in 2022 at "Rheumatology"
DOI: 10.1136/annrheumdis-2022-eular.694
Abstract: OBJECTIVES Although the painful and disabling features of early diffuse cutaneous systemic sclerosis (dcSSc) have an inflammatory basis and could respond to corticosteroids, corticosteroids are a risk factor for scleroderma renal crisis. Whether or not… read more here.
Keywords: prednisolone; systemic sclerosis; trial; diffuse cutaneous ... See more keywords
Cutaneous and Systemic Psoriasis: Classifications and Classification for the Distinction
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2021.649408
Abstract: Psoriasis is a chronic multisystem inflammatory disease that affects ~0.1–1.5% of the world population. The classic cutaneous manifestation of psoriasis is scaly erythematous plaques, limited or widely distributed. Moreover, psoriasis could be associated with comorbidities… read more here.
Keywords: psoriasis; cutaneous systemic; classification distinction; systemic psoriasis ... See more keywords
Human hepatitis viruses-associated cutaneous and systemic vasculitis
Sign Up to like & getrecommendations! Published in 2021 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v27.i1.19
Abstract: Human hepatitis viruses (HHVs) include hepatitis A virus, hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis delta virus, and hepatitis E virus and can cause liver inflammation in their common human host. Usually, HHV… read more here.
Keywords: vasculitis; systemic vasculitis; hepatitis; hepatitis virus ... See more keywords